Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00306163
Status:
COMPLETED
Last Update Posted:
2017-02-01
First Post:
2006-03-22
Brief Title:
Responsiveness of Lower Airways in Adult Patients 18-60 Years With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate BY9010NL-101
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Nebulizer Trial Evaluation of the Influence of Particle Size of Aerosolized AMP on Bronchial Responsiveness in Patients With Asthma and the Effects of Treatment With Ciclesonide Versus Fluticasone
Status:
COMPLETED
Status Verified Date:
2016-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to compare the responsiveness of lower airways in adult patients with stable asthma after treatment with ciclesonide and fluticasone propionate Treatment medication will be administered as follows ciclesonide will be inhaled once daily at one dose level fluticasone propionate will be inhaled twice daily at one dose level The study duration consists of a baseline period 5 weeks and a treatment period 5 weeks The study will provide further data on safety and tolerability of ciclesonide
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None